Global Cellular Human Tissue-engineered Skin Substitute Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cellular Human Tissue-engineered Skin Substitute Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Cellular Human Tissue-engineered Skin Substitute by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Cellular Human Tissue-engineered Skin Substitute by Country/Region, 2017, 2022 & 2028

2.2 Cellular Human Tissue-engineered Skin Substitute Segment by Type

2.2.1 Cellular Allogeneic

2.2.2 Cellular Autologous

2.2.3 Others

2.3 Cellular Human Tissue-engineered Skin Substitute Sales by Type

2.3.1 Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Type (2017-2022)

2.3.2 Global Cellular Human Tissue-engineered Skin Substitute Revenue and Market Share by Type (2017-2022)

2.3.3 Global Cellular Human Tissue-engineered Skin Substitute Sale Price by Type (2017-2022)

2.4 Cellular Human Tissue-engineered Skin Substitute Segment by Application

2.4.1 Hospitals

2.4.2 Specialty Clinics

2.4.3 Wound Care Centers

2.5 Cellular Human Tissue-engineered Skin Substitute Sales by Application

2.5.1 Global Cellular Human Tissue-engineered Skin Substitute Sale Market Share by Application (2017-2022)

2.5.2 Global Cellular Human Tissue-engineered Skin Substitute Revenue and Market Share by Application (2017-2022)

2.5.3 Global Cellular Human Tissue-engineered Skin Substitute Sale Price by Application (2017-2022)

3 Global Cellular Human Tissue-engineered Skin Substitute by Company

3.1 Global Cellular Human Tissue-engineered Skin Substitute Breakdown Data by Company

3.1.1 Global Cellular Human Tissue-engineered Skin Substitute Annual Sales by Company (2020-2022)

3.1.2 Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Company (2020-2022)

3.2 Global Cellular Human Tissue-engineered Skin Substitute Annual Revenue by Company (2020-2022)

3.2.1 Global Cellular Human Tissue-engineered Skin Substitute Revenue by Company (2020-2022)

3.2.2 Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Company (2020-2022)

3.3 Global Cellular Human Tissue-engineered Skin Substitute Sale Price by Company

3.4 Key Manufacturers Cellular Human Tissue-engineered Skin Substitute Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Cellular Human Tissue-engineered Skin Substitute Product Location Distribution

3.4.2 Players Cellular Human Tissue-engineered Skin Substitute Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Cellular Human Tissue-engineered Skin Substitute by Geographic Region

4.1 World Historic Cellular Human Tissue-engineered Skin Substitute Market Size by Geographic Region (2017-2022)

4.1.1 Global Cellular Human Tissue-engineered Skin Substitute Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Cellular Human Tissue-engineered Skin Substitute Annual Revenue by Geographic Region

4.2 World Historic Cellular Human Tissue-engineered Skin Substitute Market Size by Country/Region (2017-2022)

4.2.1 Global Cellular Human Tissue-engineered Skin Substitute Annual Sales by Country/Region (2017-2022)

4.2.2 Global Cellular Human Tissue-engineered Skin Substitute Annual Revenue by Country/Region

4.3 Americas Cellular Human Tissue-engineered Skin Substitute Sales Growth

4.4 APAC Cellular Human Tissue-engineered Skin Substitute Sales Growth

4.5 Europe Cellular Human Tissue-engineered Skin Substitute Sales Growth

4.6 Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Sales Growth

5 Americas

5.1 Americas Cellular Human Tissue-engineered Skin Substitute Sales by Country

5.1.1 Americas Cellular Human Tissue-engineered Skin Substitute Sales by Country (2017-2022)

5.1.2 Americas Cellular Human Tissue-engineered Skin Substitute Revenue by Country (2017-2022)

5.2 Americas Cellular Human Tissue-engineered Skin Substitute Sales by Type

5.3 Americas Cellular Human Tissue-engineered Skin Substitute Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Cellular Human Tissue-engineered Skin Substitute Sales by Region

6.1.1 APAC Cellular Human Tissue-engineered Skin Substitute Sales by Region (2017-2022)

6.1.2 APAC Cellular Human Tissue-engineered Skin Substitute Revenue by Region (2017-2022)

6.2 APAC Cellular Human Tissue-engineered Skin Substitute Sales by Type

6.3 APAC Cellular Human Tissue-engineered Skin Substitute Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Cellular Human Tissue-engineered Skin Substitute by Country

7.1.1 Europe Cellular Human Tissue-engineered Skin Substitute Sales by Country (2017-2022)

7.1.2 Europe Cellular Human Tissue-engineered Skin Substitute Revenue by Country (2017-2022)

7.2 Europe Cellular Human Tissue-engineered Skin Substitute Sales by Type

7.3 Europe Cellular Human Tissue-engineered Skin Substitute Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Cellular Human Tissue-engineered Skin Substitute by Country

8.1.1 Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Sales by Country (2017-2022)

8.1.2 Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Revenue by Country (2017-2022)

8.2 Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Sales by Type

8.3 Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Cellular Human Tissue-engineered Skin Substitute

10.3 Manufacturing Process Analysis of Cellular Human Tissue-engineered Skin Substitute

10.4 Industry Chain Structure of Cellular Human Tissue-engineered Skin Substitute

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Cellular Human Tissue-engineered Skin Substitute Distributors

11.3 Cellular Human Tissue-engineered Skin Substitute Customer

12 World Forecast Review for Cellular Human Tissue-engineered Skin Substitute by Geographic Region

12.1 Global Cellular Human Tissue-engineered Skin Substitute Market Size Forecast by Region

12.1.1 Global Cellular Human Tissue-engineered Skin Substitute Forecast by Region (2023-2028)

12.1.2 Global Cellular Human Tissue-engineered Skin Substitute Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Cellular Human Tissue-engineered Skin Substitute Forecast by Type

12.7 Global Cellular Human Tissue-engineered Skin Substitute Forecast by Application

13 Key Players Analysis

13.1 Allergan (AbbVie)

13.1.1 Allergan (AbbVie) Company Information

13.1.2 Allergan (AbbVie) Cellular Human Tissue-engineered Skin Substitute Product Offered

13.1.3 Allergan (AbbVie) Cellular Human Tissue-engineered Skin Substitute Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Allergan (AbbVie) Main Business Overview

13.1.5 Allergan (AbbVie) Latest Developments

13.2 AlloSource

13.2.1 AlloSource Company Information

13.2.2 AlloSource Cellular Human Tissue-engineered Skin Substitute Product Offered

13.2.3 AlloSource Cellular Human Tissue-engineered Skin Substitute Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 AlloSource Main Business Overview

13.2.5 AlloSource Latest Developments

13.3 Organogenesis

13.3.1 Organogenesis Company Information

13.3.2 Organogenesis Cellular Human Tissue-engineered Skin Substitute Product Offered

13.3.3 Organogenesis Cellular Human Tissue-engineered Skin Substitute Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Organogenesis Main Business Overview

13.3.5 Organogenesis Latest Developments

13.4 BD

13.4.1 BD Company Information

13.4.2 BD Cellular Human Tissue-engineered Skin Substitute Product Offered

13.4.3 BD Cellular Human Tissue-engineered Skin Substitute Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 BD Main Business Overview

13.4.5 BD Latest Developments

13.5 Smith & Nephew

13.5.1 Smith & Nephew Company Information

13.5.2 Smith & Nephew Cellular Human Tissue-engineered Skin Substitute Product Offered

13.5.3 Smith & Nephew Cellular Human Tissue-engineered Skin Substitute Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Smith & Nephew Main Business Overview

13.5.5 Smith & Nephew Latest Developments

13.6 Integra LifeSciences

13.6.1 Integra LifeSciences Company Information

13.6.2 Integra LifeSciences Cellular Human Tissue-engineered Skin Substitute Product Offered

13.6.3 Integra LifeSciences Cellular Human Tissue-engineered Skin Substitute Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Integra LifeSciences Main Business Overview

13.6.5 Integra LifeSciences Latest Developments

13.7 Synthes (Johnson & Johnson)

13.7.1 Synthes (Johnson & Johnson) Company Information

13.7.2 Synthes (Johnson & Johnson) Cellular Human Tissue-engineered Skin Substitute Product Offered

13.7.3 Synthes (Johnson & Johnson) Cellular Human Tissue-engineered Skin Substitute Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Synthes (Johnson & Johnson) Main Business Overview

13.7.5 Synthes (Johnson & Johnson) Latest Developments

13.8 Axogen

13.8.1 Axogen Company Information

13.8.2 Axogen Cellular Human Tissue-engineered Skin Substitute Product Offered

13.8.3 Axogen Cellular Human Tissue-engineered Skin Substitute Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Axogen Main Business Overview

13.8.5 Axogen Latest Developments

13.9 Vericel Corporation

13.9.1 Vericel Corporation Company Information

13.9.2 Vericel Corporation Cellular Human Tissue-engineered Skin Substitute Product Offered

13.9.3 Vericel Corporation Cellular Human Tissue-engineered Skin Substitute Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Vericel Corporation Main Business Overview

13.9.5 Vericel Corporation Latest Developments

13.10 LifeNet Health

13.10.1 LifeNet Health Company Information

13.10.2 LifeNet Health Cellular Human Tissue-engineered Skin Substitute Product Offered

13.10.3 LifeNet Health Cellular Human Tissue-engineered Skin Substitute Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 LifeNet Health Main Business Overview

13.10.5 LifeNet Health Latest Developments

13.11 MTF Biologics

13.11.1 MTF Biologics Company Information

13.11.2 MTF Biologics Cellular Human Tissue-engineered Skin Substitute Product Offered

13.11.3 MTF Biologics Cellular Human Tissue-engineered Skin Substitute Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 MTF Biologics Main Business Overview

13.11.5 MTF Biologics Latest Developments

13.12 Arthrex

13.12.1 Arthrex Company Information

13.12.2 Arthrex Cellular Human Tissue-engineered Skin Substitute Product Offered

13.12.3 Arthrex Cellular Human Tissue-engineered Skin Substitute Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Arthrex Main Business Overview

13.12.5 Arthrex Latest Developments

13.13 Wright Medical Group NV (Stryker)

13.13.1 Wright Medical Group NV (Stryker) Company Information

13.13.2 Wright Medical Group NV (Stryker) Cellular Human Tissue-engineered Skin Substitute Product Offered

13.13.3 Wright Medical Group NV (Stryker) Cellular Human Tissue-engineered Skin Substitute Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Wright Medical Group NV (Stryker) Main Business Overview

13.13.5 Wright Medical Group NV (Stryker) Latest Developments

13.14 Cook Biotech Incorporated

13.14.1 Cook Biotech Incorporated Company Information

13.14.2 Cook Biotech Incorporated Cellular Human Tissue-engineered Skin Substitute Product Offered

13.14.3 Cook Biotech Incorporated Cellular Human Tissue-engineered Skin Substitute Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Cook Biotech Incorporated Main Business Overview

13.14.5 Cook Biotech Incorporated Latest Developments

13.15 Aroa Biosurgery

13.15.1 Aroa Biosurgery Company Information

13.15.2 Aroa Biosurgery Cellular Human Tissue-engineered Skin Substitute Product Offered

13.15.3 Aroa Biosurgery Cellular Human Tissue-engineered Skin Substitute Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Aroa Biosurgery Main Business Overview

13.15.5 Aroa Biosurgery Latest Developments

13.16 Surgalign Holdings

13.16.1 Surgalign Holdings Company Information

13.16.2 Surgalign Holdings Cellular Human Tissue-engineered Skin Substitute Product Offered

13.16.3 Surgalign Holdings Cellular Human Tissue-engineered Skin Substitute Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Surgalign Holdings Main Business Overview

13.16.5 Surgalign Holdings Latest Developments

14 Research Findings and Conclusion

Table 1. Cellular Human Tissue-engineered Skin Substitute Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Cellular Human Tissue-engineered Skin Substitute Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Cellular Allogeneic

Table 4. Major Players of Cellular Autologous

Table 5. Major Players of Others

Table 6. Global Cellular Human Tissue-engineered Skin Substitute Sales by Type (2017-2022) & (K Units)

Table 7. Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Type (2017-2022)

Table 8. Global Cellular Human Tissue-engineered Skin Substitute Revenue by Type (2017-2022) & ($ million)

Table 9. Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Type (2017-2022)

Table 10. Global Cellular Human Tissue-engineered Skin Substitute Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global Cellular Human Tissue-engineered Skin Substitute Sales by Application (2017-2022) & (K Units)

Table 12. Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Application (2017-2022)

Table 13. Global Cellular Human Tissue-engineered Skin Substitute Revenue by Application (2017-2022)

Table 14. Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Application (2017-2022)

Table 15. Global Cellular Human Tissue-engineered Skin Substitute Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global Cellular Human Tissue-engineered Skin Substitute Sales by Company (2020-2022) & (K Units)

Table 17. Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Company (2020-2022)

Table 18. Global Cellular Human Tissue-engineered Skin Substitute Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Company (2020-2022)

Table 20. Global Cellular Human Tissue-engineered Skin Substitute Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Cellular Human Tissue-engineered Skin Substitute Producing Area Distribution and Sales Area

Table 22. Players Cellular Human Tissue-engineered Skin Substitute Products Offered

Table 23. Cellular Human Tissue-engineered Skin Substitute Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Cellular Human Tissue-engineered Skin Substitute Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share Geographic Region (2017-2022)

Table 28. Global Cellular Human Tissue-engineered Skin Substitute Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Cellular Human Tissue-engineered Skin Substitute Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Country/Region (2017-2022)

Table 32. Global Cellular Human Tissue-engineered Skin Substitute Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Cellular Human Tissue-engineered Skin Substitute Sales by Country (2017-2022) & (K Units)

Table 35. Americas Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Country (2017-2022)

Table 36. Americas Cellular Human Tissue-engineered Skin Substitute Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Country (2017-2022)

Table 38. Americas Cellular Human Tissue-engineered Skin Substitute Sales by Type (2017-2022) & (K Units)

Table 39. Americas Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Type (2017-2022)

Table 40. Americas Cellular Human Tissue-engineered Skin Substitute Sales by Application (2017-2022) & (K Units)

Table 41. Americas Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Application (2017-2022)

Table 42. APAC Cellular Human Tissue-engineered Skin Substitute Sales by Region (2017-2022) & (K Units)

Table 43. APAC Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Region (2017-2022)

Table 44. APAC Cellular Human Tissue-engineered Skin Substitute Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Region (2017-2022)

Table 46. APAC Cellular Human Tissue-engineered Skin Substitute Sales by Type (2017-2022) & (K Units)

Table 47. APAC Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Type (2017-2022)

Table 48. APAC Cellular Human Tissue-engineered Skin Substitute Sales by Application (2017-2022) & (K Units)

Table 49. APAC Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Application (2017-2022)

Table 50. Europe Cellular Human Tissue-engineered Skin Substitute Sales by Country (2017-2022) & (K Units)

Table 51. Europe Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Country (2017-2022)

Table 52. Europe Cellular Human Tissue-engineered Skin Substitute Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Country (2017-2022)

Table 54. Europe Cellular Human Tissue-engineered Skin Substitute Sales by Type (2017-2022) & (K Units)

Table 55. Europe Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Type (2017-2022)

Table 56. Europe Cellular Human Tissue-engineered Skin Substitute Sales by Application (2017-2022) & (K Units)

Table 57. Europe Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Cellular Human Tissue-engineered Skin Substitute

Table 67. Key Market Challenges & Risks of Cellular Human Tissue-engineered Skin Substitute

Table 68. Key Industry Trends of Cellular Human Tissue-engineered Skin Substitute

Table 69. Cellular Human Tissue-engineered Skin Substitute Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Cellular Human Tissue-engineered Skin Substitute Distributors List

Table 72. Cellular Human Tissue-engineered Skin Substitute Customer List

Table 73. Global Cellular Human Tissue-engineered Skin Substitute Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Cellular Human Tissue-engineered Skin Substitute Sales Market Forecast by Region

Table 75. Global Cellular Human Tissue-engineered Skin Substitute Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Cellular Human Tissue-engineered Skin Substitute Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Cellular Human Tissue-engineered Skin Substitute Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Cellular Human Tissue-engineered Skin Substitute Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Cellular Human Tissue-engineered Skin Substitute Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Cellular Human Tissue-engineered Skin Substitute Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Cellular Human Tissue-engineered Skin Substitute Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Cellular Human Tissue-engineered Skin Substitute Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Cellular Human Tissue-engineered Skin Substitute Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Cellular Human Tissue-engineered Skin Substitute Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Cellular Human Tissue-engineered Skin Substitute Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share Forecast by Application (2023-2028)

Table 93. Allergan (AbbVie) Basic Information, Cellular Human Tissue-engineered Skin Substitute Manufacturing Base, Sales Area and Its Competitors

Table 94. Allergan (AbbVie) Cellular Human Tissue-engineered Skin Substitute Product Offered

Table 95. Allergan (AbbVie) Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. Allergan (AbbVie) Main Business

Table 97. Allergan (AbbVie) Latest Developments

Table 98. AlloSource Basic Information, Cellular Human Tissue-engineered Skin Substitute Manufacturing Base, Sales Area and Its Competitors

Table 99. AlloSource Cellular Human Tissue-engineered Skin Substitute Product Offered

Table 100. AlloSource Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. AlloSource Main Business

Table 102. AlloSource Latest Developments

Table 103. Organogenesis Basic Information, Cellular Human Tissue-engineered Skin Substitute Manufacturing Base, Sales Area and Its Competitors

Table 104. Organogenesis Cellular Human Tissue-engineered Skin Substitute Product Offered

Table 105. Organogenesis Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Organogenesis Main Business

Table 107. Organogenesis Latest Developments

Table 108. BD Basic Information, Cellular Human Tissue-engineered Skin Substitute Manufacturing Base, Sales Area and Its Competitors

Table 109. BD Cellular Human Tissue-engineered Skin Substitute Product Offered

Table 110. BD Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. BD Main Business

Table 112. BD Latest Developments

Table 113. Smith & Nephew Basic Information, Cellular Human Tissue-engineered Skin Substitute Manufacturing Base, Sales Area and Its Competitors

Table 114. Smith & Nephew Cellular Human Tissue-engineered Skin Substitute Product Offered

Table 115. Smith & Nephew Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. Smith & Nephew Main Business

Table 117. Smith & Nephew Latest Developments

Table 118. Integra LifeSciences Basic Information, Cellular Human Tissue-engineered Skin Substitute Manufacturing Base, Sales Area and Its Competitors

Table 119. Integra LifeSciences Cellular Human Tissue-engineered Skin Substitute Product Offered

Table 120. Integra LifeSciences Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. Integra LifeSciences Main Business

Table 122. Integra LifeSciences Latest Developments

Table 123. Synthes (Johnson & Johnson) Basic Information, Cellular Human Tissue-engineered Skin Substitute Manufacturing Base, Sales Area and Its Competitors

Table 124. Synthes (Johnson & Johnson) Cellular Human Tissue-engineered Skin Substitute Product Offered

Table 125. Synthes (Johnson & Johnson) Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. Synthes (Johnson & Johnson) Main Business

Table 127. Synthes (Johnson & Johnson) Latest Developments

Table 128. Axogen Basic Information, Cellular Human Tissue-engineered Skin Substitute Manufacturing Base, Sales Area and Its Competitors

Table 129. Axogen Cellular Human Tissue-engineered Skin Substitute Product Offered

Table 130. Axogen Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. Axogen Main Business

Table 132. Axogen Latest Developments

Table 133. Vericel Corporation Basic Information, Cellular Human Tissue-engineered Skin Substitute Manufacturing Base, Sales Area and Its Competitors

Table 134. Vericel Corporation Cellular Human Tissue-engineered Skin Substitute Product Offered

Table 135. Vericel Corporation Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 136. Vericel Corporation Main Business

Table 137. Vericel Corporation Latest Developments

Table 138. LifeNet Health Basic Information, Cellular Human Tissue-engineered Skin Substitute Manufacturing Base, Sales Area and Its Competitors

Table 139. LifeNet Health Cellular Human Tissue-engineered Skin Substitute Product Offered

Table 140. LifeNet Health Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 141. LifeNet Health Main Business

Table 142. LifeNet Health Latest Developments

Table 143. MTF Biologics Basic Information, Cellular Human Tissue-engineered Skin Substitute Manufacturing Base, Sales Area and Its Competitors

Table 144. MTF Biologics Cellular Human Tissue-engineered Skin Substitute Product Offered

Table 145. MTF Biologics Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 146. MTF Biologics Main Business

Table 147. MTF Biologics Latest Developments

Table 148. Arthrex Basic Information, Cellular Human Tissue-engineered Skin Substitute Manufacturing Base, Sales Area and Its Competitors

Table 149. Arthrex Cellular Human Tissue-engineered Skin Substitute Product Offered

Table 150. Arthrex Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 151. Arthrex Main Business

Table 152. Arthrex Latest Developments

Table 153. Wright Medical Group NV (Stryker) Basic Information, Cellular Human Tissue-engineered Skin Substitute Manufacturing Base, Sales Area and Its Competitors

Table 154. Wright Medical Group NV (Stryker) Cellular Human Tissue-engineered Skin Substitute Product Offered

Table 155. Wright Medical Group NV (Stryker) Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 156. Wright Medical Group NV (Stryker) Main Business

Table 157. Wright Medical Group NV (Stryker) Latest Developments

Table 158. Cook Biotech Incorporated Basic Information, Cellular Human Tissue-engineered Skin Substitute Manufacturing Base, Sales Area and Its Competitors

Table 159. Cook Biotech Incorporated Cellular Human Tissue-engineered Skin Substitute Product Offered

Table 160. Cook Biotech Incorporated Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 161. Cook Biotech Incorporated Main Business

Table 162. Cook Biotech Incorporated Latest Developments

Table 163. Aroa Biosurgery Basic Information, Cellular Human Tissue-engineered Skin Substitute Manufacturing Base, Sales Area and Its Competitors

Table 164. Aroa Biosurgery Cellular Human Tissue-engineered Skin Substitute Product Offered

Table 165. Aroa Biosurgery Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 166. Aroa Biosurgery Main Business

Table 167. Aroa Biosurgery Latest Developments

Table 168. Surgalign Holdings Basic Information, Cellular Human Tissue-engineered Skin Substitute Manufacturing Base, Sales Area and Its Competitors

Table 169. Surgalign Holdings Cellular Human Tissue-engineered Skin Substitute Product Offered

Table 170. Surgalign Holdings Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 171. Surgalign Holdings Main Business

Table 172. Surgalign Holdings Latest Developments

List of Figures

Figure 1. Picture of Cellular Human Tissue-engineered Skin Substitute

Figure 2. Cellular Human Tissue-engineered Skin Substitute Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Cellular Human Tissue-engineered Skin Substitute Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Cellular Human Tissue-engineered Skin Substitute Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Cellular Human Tissue-engineered Skin Substitute Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Cellular Allogeneic

Figure 10. Product Picture of Cellular Autologous

Figure 11. Product Picture of Others

Figure 12. Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Type in 2021

Figure 13. Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Type (2017-2022)

Figure 14. Cellular Human Tissue-engineered Skin Substitute Consumed in Hospitals

Figure 15. Global Cellular Human Tissue-engineered Skin Substitute Market: Hospitals (2017-2022) & (K Units)

Figure 16. Cellular Human Tissue-engineered Skin Substitute Consumed in Specialty Clinics

Figure 17. Global Cellular Human Tissue-engineered Skin Substitute Market: Specialty Clinics (2017-2022) & (K Units)

Figure 18. Cellular Human Tissue-engineered Skin Substitute Consumed in Wound Care Centers

Figure 19. Global Cellular Human Tissue-engineered Skin Substitute Market: Wound Care Centers (2017-2022) & (K Units)

Figure 20. Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Application (2017-2022)

Figure 21. Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Application in 2021

Figure 22. Cellular Human Tissue-engineered Skin Substitute Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Company in 2021

Figure 24. Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Geographic Region in 2021

Figure 26. Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Region (2017-2022)

Figure 27. Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Country/Region in 2021

Figure 28. Americas Cellular Human Tissue-engineered Skin Substitute Sales 2017-2022 (K Units)

Figure 29. Americas Cellular Human Tissue-engineered Skin Substitute Revenue 2017-2022 ($ Millions)

Figure 30. APAC Cellular Human Tissue-engineered Skin Substitute Sales 2017-2022 (K Units)

Figure 31. APAC Cellular Human Tissue-engineered Skin Substitute Revenue 2017-2022 ($ Millions)

Figure 32. Europe Cellular Human Tissue-engineered Skin Substitute Sales 2017-2022 (K Units)

Figure 33. Europe Cellular Human Tissue-engineered Skin Substitute Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Revenue 2017-2022 ($ Millions)

Figure 36. Americas Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Country in 2021

Figure 37. Americas Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Country in 2021

Figure 38. United States Cellular Human Tissue-engineered Skin Substitute Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Cellular Human Tissue-engineered Skin Substitute Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Cellular Human Tissue-engineered Skin Substitute Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Cellular Human Tissue-engineered Skin Substitute Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Region in 2021

Figure 43. APAC Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Regions in 2021

Figure 44. China Cellular Human Tissue-engineered Skin Substitute Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Cellular Human Tissue-engineered Skin Substitute Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Cellular Human Tissue-engineered Skin Substitute Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Cellular Human Tissue-engineered Skin Substitute Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Cellular Human Tissue-engineered Skin Substitute Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Cellular Human Tissue-engineered Skin Substitute Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Country in 2021

Figure 51. Europe Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Country in 2021

Figure 52. Germany Cellular Human Tissue-engineered Skin Substitute Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Cellular Human Tissue-engineered Skin Substitute Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Cellular Human Tissue-engineered Skin Substitute Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Cellular Human Tissue-engineered Skin Substitute Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Cellular Human Tissue-engineered Skin Substitute Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Country in 2021

Figure 59. Egypt Cellular Human Tissue-engineered Skin Substitute Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Cellular Human Tissue-engineered Skin Substitute Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Cellular Human Tissue-engineered Skin Substitute Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Cellular Human Tissue-engineered Skin Substitute Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Cellular Human Tissue-engineered Skin Substitute Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Cellular Human Tissue-engineered Skin Substitute in 2021

Figure 65. Manufacturing Process Analysis of Cellular Human Tissue-engineered Skin Substitute

Figure 66. Industry Chain Structure of Cellular Human Tissue-engineered Skin Substitute

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles